Effects of Magnesium on Blood Pressure in Patients with familiarity for Metabolic Syndrome - ND

AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA0 个研究点开始时间: 2009年11月5日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Healthy subjects, non suffering Hypertension, non diabetic, non obese, at the age between 18 and 50 years, with at least a relative suffering from metabolic syndrome (NCEP/ATPIII criteria).
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Age below 18 and over 50, hypertension (BP≥140/90 mmHg or therapy with antihypertensive drugs), diabetes mellitus (Glycemia on empty stomach ≥126 mg/dl or therapy with antidiabetic drugs), obesity (BMI≥30 Kg/m2). Intake of hypocholesteromizant drugs, NSAIDs or other type (if continuative use). Use of magnesium supplementations or vitamin complexes. Hypermagnesemia before randomization. Previous cardiac and/or cerebrovascular events. Chronic kidney failure. Chronic inflammatory liver or renal diseases, malignant cancer, gastrointestinal dysfunctions with hypomotility. Unability to give informed consent.

发起方

AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA